Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Trump Dashboard

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

Sanofi (FR:SAN)

:SAN

France Market

SAN

Sanofi

Analyst Forecasts

AI Stock Analysis

Technical Analysis

Historical Prices

News & Insights

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Sanofi (SAN) Stock News & Sentiment

193 Followers

Sanofi’s Promising Phase 2a Study on FSGS and MCD: A Potential Game-Changer

Company Announcements

Sanofi’s Promising Phase 2a Study on FSGS and MCD: A Potential Game-Changer

3d ago

Regeneron and Sanofi’s Dupilumab Study: A Potential Breakthrough for Pediatric Asthma

Company Announcements

Regeneron and Sanofi’s Dupilumab Study: A Potential Breakthrough for Pediatric Asthma

3d ago

Sanofi’s Observational Study on Isatuximab: Potential Market Impacts

Company Announcements

Sanofi’s Observational Study on Isatuximab: Potential Market Impacts

3d ago

Sanofi’s Promising Drug Pipeline and Undervaluation Drive Buy Rating

Ratings

Sanofi’s Promising Drug Pipeline and Undervaluation Drive Buy Rating

3d ago

Regeneron and Sanofi’s Phase 3 Trial for Itepekimab: A Potential Game-Changer in Chronic Rhinosinusitis Treatment

Company Announcements

Regeneron and Sanofi’s Phase 3 Trial for Itepekimab: A Potential Game-Changer in Chronic Rhinosinusitis Treatment

4d ago

Regeneron and Sanofi’s Dupilumab Study: A Potential Game-Changer for Pediatric Prurigo Nodularis

Company Announcements

Regeneron and Sanofi’s Dupilumab Study: A Potential Game-Changer for Pediatric Prurigo Nodularis

4d ago

Regeneron and Sanofi’s Dupilumab Study: Long-Term Safety Insights for Pediatric Atopic Dermatitis

Company Announcements

Regeneron and Sanofi’s Dupilumab Study: Long-Term Safety Insights for Pediatric Atopic Dermatitis

4d ago

More FR:SAN News >

SAN News on the Web

2025-06-26

RFK Jr.'s CDC vaccine panel backs Merck RSV shot for infants

CNBC

Neutral

2025-06-23

Sanofi's Sarclisa Recommended For EU Approval To Treat Transplant-eligible Newly Diagnosed MM

rttnews

Neutral

2025-06-21

Sanofi (ENXTPA:SAN) Gains FDA Approval For Dupixent To Address Rare Skin Disease

Simply Wall St

Neutral

2025-06-20

Regeneron, Sanofi: FDA Approves Dupixent To Treat Adult Patients With Bullous Pemphigoid

rttnews

Neutral

2025-06-18

RFK Jr.’s new vaccine advisors will vote on flu shots containing mercury

CNBC

Neutral

2025-06-15

Sanofi : Dupixent Shows Superior Results To Xolair In Phase 4 Study For Sinus And Asthma Treatment

rttnews

Neutral

2025-06-10

Sanofi (ENXTPA:SAN) Expands Beyfortus RSV Protection Production For Global Demand

Simply Wall St

Bullish

2025-06-09

Tuesday’s big stock stories: What’s likely to move the market in the next trading session

CNBC

Neutral

News Score - Last 7 Days

Neutral

FR:SAN

Sector Average

Media Buzz

This Week2 articles

Weekly Average4.25 articles

News Sentiment

This Week59%

Sector Average56%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FR:SAN’s Media Buzz Sentiment?

2 articles about FR:SAN were published this week. In an average week, 4.25 articles are published.

What is FR:SAN’s weekly average amount of articles?

In an average week, 4.25 articles about FR:SAN are published.

What is FR:SAN’s News Sentiment?

59% of articles about FR:SAN were positive this week, compared to its sector average of 56%.

Healthcare Stocks that are Trending in the News

BSXBoston Scientific

VEEVVeeva Systems

AUPHAurinia Pharmaceuticals

AMNAMN Healthcare Services

SCLPScancell Holdings

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing